- 专利标题： INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
-
申请号： EP20208058.6申请日： 2014-12-05
-
公开(公告)号： EP3861982A3公开(公告)日： 2021-09-01
- 发明人: Maynor, Benjamin , Garcia, Andres , Das, Sanjib Kumar , Navratil, Tomas , Yerxa, Benjamin Robinson , Tully, Janet
- 申请人： ALLERGAN, INC.
- 申请人地址： US Irvine, CA 92612 2525 Dupont Drive
- 代理机构： Hoffmann Eitle
- 优先权： US201461987902 P 20140502
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K47/34 ; A61K31/5575 ; A61P27/06 ; A61P27/02
摘要：
The present invention relates to a pharmaceutical composition for treating an ocular condition, comprising a biodegradable polymer matrix and at least one therapeutic agent homogenously dispersed within the polymer matrix. The composition can be in the form of an ocular implant.
公开/授权文献
- EP3861982A2 INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION 公开/授权日：2021-08-11
信息查询
